![Joel A. Fernandes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joel A. Fernandes
Nessuna posizione attualmente
Profilo
Joel A.
Fernandes formerly worked at Innoviva, Inc., as Associate Director-Finance from 2005 to 2006, Innoviva, Inc., as Associate Director-Finance, ALZA Corp., as Assistant Controller from 1999 to 2002, KLA Corp., as Senior Manager-Corporate Finance from 2002 to 2005, and Threshold Pharmaceuticals, Inc., as Senior Vice President-Finance & Controller.
Mr. Fernandes received his graduate degree from Manchester College.
Precedenti posizioni note di Joel A. Fernandes
Società | Posizione | Fine |
---|---|---|
INNOVIVA, INC. | Corporate Officer/Principal | 01/03/2006 |
KLA CORPORATION | Corporate Officer/Principal | 01/01/2005 |
ALZA CORPORATION | Corporate Officer/Principal | 01/01/2002 |
INNOVIVA, INC. | Corporate Officer/Principal | - |
Threshold Pharmaceuticals, Inc.
![]() Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Direttore Finanziario/CFO | - |
Formazione di Joel A. Fernandes
Manchester College | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
INNOVIVA, INC. | Health Technology |
KLA CORPORATION | Electronic Technology |
Aziende private | 2 |
---|---|
Threshold Pharmaceuticals, Inc.
![]() Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Threshold Pharmaceuticals, Inc. engages in the development of therapeutics for treating tumors. It offers the Evofosfamide which designed as a prodrug that is activated under the extreme hypoxic conditions commonly found in tumors, but not typically in healthy tissues, and TH-3424 which is a small-molecule drug candidate for the treatment of liver, castrate resistant prostate cancer, T-cell acute lymphoblastic leukemias, and other cancers. The company was founded by Jeffrey W. Bird on October 17, 2001 and is headquartered in South San Francisco, CA | Health Technology |
ALZA Corp.
![]() ALZA Corp. Pharmaceuticals: MajorHealth Technology ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA. | Health Technology |
- Borsa valori
- Insiders
- Joel A. Fernandes